WELL Health Technologies Corp., a digital healthcare company focused on improving health outcomes through technology and ...
Bitcoin rallied Wednesday, hitting all-time highs as former President Donald Trump defeated Vice President Kamala Harris to win the White House. The price of the flagship cryptocurrency was last ...
Stocks rallied sharply on Wednesday, with major benchmarks hitting record highs, as Donald Trump won the 2024 presidential election. The Dow Jones Industrial Average surged 1,508.05 points, or 3.57%, ...
AbCellera Forward-looking Statements. This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Secur ...
D-Wave Quantum Inc., a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, announced it has achieved "Awardable" status through ...
Qmetrix, North America's only provider of Interconnected Commerce solutions for telecom retail, has unveiled two brand-new product suites that it is preparing to launch to market in the coming months, ...
Burcon NutraScience Corporation , a global technology leader in the development of plant-based proteins for foods and beverages, announced the successful completion of a process scale-up project for a ...
Deloitte Canada announced the winners of its Technology Fast 50, Enterprise—Industry Leaders, Clean Technology, and Companies-to-Watch awards. Now in its 27th year, the Technology Fast 50TM program ...
Ballard Power Systems announced a purchase order to supply 200 fuel cell engines to New Flyer, a subsidiary of NFI Group Inc.
TELUS Global Ventures announced that it is participating in two new funding rounds with equity investments in Homethrive and ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...
Jade Biosciences, Inc., a privately held biotechnology company dedicated to developing best-in-class therapies for patients ...